RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Transplant Rejection
Accession: DOID:9004283
browse the term
Definition: A process in which a transplant recipient's immune system attacks the transplanted organ or tissue. The rejection can be hyperacute (occurring within a few minutes), acute (occurring within days to months), or chronic (occurring over many years).
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Apoa1
apolipoprotein A1
ISO
protein:decreased expression:plasma
RGD
PMID:21730889
RGD:7241209
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Arrb1
arrestin, beta 1
IEP
mRNA:decreased expression:blood, leukocyte
RGD
PMID:21193245
RGD:13506894
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
G
Arrb2
arrestin, beta 2
IEP
mRNA, protein:decreased expression:blood, leukocyte, monocyte
RGD
PMID:21193245
RGD:13506894
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Bag6
BAG cochaperone 6
susceptibility
ISO
DNA:haplotype: :rs10484558(human)
RGD
PMID:25111513
RGD:14390152
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
G
Ccl2
C-C motif chemokine ligand 2
susceptibility
ISO
kidney;DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:12239249 PMID:14662900
RGD:8548879 , RGD:8657367
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:20688906
RGD:7241797
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:14662900
RGD:8657367
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
treatment
IEP
RGD
PMID:23498802 PMID:23446583
RGD:8552228 , RGD:8552231
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd274
CD274 molecule
ISO
RGD
PMID:14662900
RGD:8657367
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd4
Cd4 molecule
treatment
IMP ISO
RGD
PMID:1704648 PMID:11081762
RGD:10058956 , RGD:10058974
NCBI chr 4:157,668,878...157,695,366
G
Cd40
CD40 molecule
disease_progression treatment
ISO IMP
associated with Diabetes Mellitus, Experimental
RGD
PMID:15221125 PMID:14698004 PMID:21472009
RGD:7248441 , RGD:8547788 , RGD:7248755
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
ISO IMP
protein:increased expression:blood, T cell associated with Diabetes Mellitus
RGD
PMID:22948742 PMID:15808676 PMID:10949194 PMID:15016184
RGD:7248420 , RGD:8547783 , RGD:7248719 , RGD:7248598
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
IEP
RGD
PMID:25121092
RGD:151347544
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
IEP
RGD
PMID:25121092
RGD:151347544
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Col1a2
collagen type I alpha 2 chain
ISO
mRNA:increased expression:kidney
RGD
PMID:20150539
RGD:7248773
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
ISO
mRNA:increased expression:kidney
RGD
PMID:20150539
RGD:7248773
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Csf1
colony stimulating factor 1
ISO IEP
mRNA:increased expression:kidney
RGD
PMID:19196448 PMID:11981428
RGD:7257570 , RGD:7257590
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
IMP
RGD
PMID:24056626
RGD:151665812
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:18589159
RGD:11039422
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO IMP
DNA:SNP: :rs231775, korean(human) DNA:SNP: :rs733618, chinese(human)
RGD
PMID:12096784 PMID:20940051 PMID:22418270 PMID:18074399 PMID:14551031
RGD:7204515 , RGD:7204678 , RGD:7204671 , RGD:7204518 , RGD:7204516
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
ISO
RGD
PMID:28245475
RGD:27095950
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
DNA:SNP:promoter:g.-2668G>A (rs2671222) (human)
RGD
PMID:21452410
RGD:7257676
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP IEP
RGD
PMID:15840022 PMID:22882432
RGD:7257683 , RGD:7257690
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Dhodh
dihydroorotate dehydrogenase (quinone)
treatment
IMP
RGD
PMID:8443191
RGD:11040447
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
G
Ece1
endothelin converting enzyme 1
IMP
RGD
PMID:10401760
RGD:7244165
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
RGD
PMID:10656876
RGD:9685445
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Ern1
endoplasmic reticulum to nucleus signaling 1
treatment
IEP
RGD
PMID:31828147
RGD:35316072
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
IMP
RGD
PMID:27784285
RGD:126781722
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Faslg
Fas ligand
IEP
mRNA, protein:increased expression:liver
RGD
PMID:10357921
RGD:14700698
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2a
Fc gamma receptor 2A
treatment
ISO
RGD
PMID:10762218
RGD:9588604
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Foxp3
forkhead box P3
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:17414718 PMID:21199671 PMID:28457422
RGD:38456005 , RGD:38599144 , RGD:38549577
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gfer
growth factor, augmenter of liver regeneration
IEP
RGD
PMID:22819311
RGD:9685732
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Got2
glutamic-oxaloacetic transaminase 2
treatment
IDA
RGD
PMID:28596681
RGD:13504864
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
G
Gstt1
glutathione S-transferase theta 1
ISO
associated with Hemoglobinopathies;DNA:deletion:: (human)
RGD
PMID:20348973
RGD:10450792
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:23435265
RGD:7244382
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Havcr2
hepatitis A virus cellular receptor 2
ISO IEP
mRNA:increased expression:Leukocytes, Mononuclear: mRNA,protein:increased expression:lung:
RGD
PMID:22172823 PMID:24508263
RGD:7245954 , RGD:9686116
NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
RGD
PMID:23953577
RGD:12910541
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Ifng
interferon gamma
ISO
RGD
PMID:22564629
RGD:7364833
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IEP IMP
mRNA:increased expression:kidney
RGD
PMID:19249479 PMID:20500684
RGD:7495769 , RGD:4892204
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
ISO IDA
RGD
PMID:22564629 PMID:17275523 PMID:23870834
RGD:7364833 , RGD:11049523 , RGD:7364994
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
treatment
ISO IEP IDA
mRNA:increased expression:liver
RGD
PMID:17902182 PMID:17532783 PMID:17331844
RGD:8549629 , RGD:10402939 , RGD:8549647
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
IEP
mRNA:increased expression:liver
RGD
PMID:17532783
RGD:10402939
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il17a
interleukin 17A
treatment
ISO IMP IEP
protein:increased expression:liver, serum (rat)
RGD
PMID:20651239 PMID:23429965 PMID:21043049
RGD:9068426 , RGD:9068938 , RGD:4781440
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
IMP
RGD
PMID:21962809
RGD:8655943
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
IMP
RGD
PMID:21962809
RGD:8655943
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1b
interleukin 1 beta
severity
ISO
DNA:snp:intron:g.3962C>T (human)
RGD
PMID:22663993 PMID:8094579
RGD:7175098 , RGD:7401188
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
cornea transplant; human protein in a mouse model
RGD
PMID:9175817
RGD:8549799
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
treatment
ISO IMP
RGD
PMID:22564629 PMID:18089405 PMID:3291556
RGD:7364833 , RGD:10047078 , RGD:8662936
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il21
interleukin 21
ISO
associated with hepatitis B;DNA:SNPs, haplotype:intron, CDS:1472G>T, 5250C>T (rs2055979, rs4833837) (human)
RGD
PMID:23656167
RGD:127285550
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il2rb
interleukin 2 receptor subunit beta
ameliorates
ISO
RGD
PMID:9293878
RGD:42733040
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il5
interleukin 5
treatment
IDA
RGD
PMID:11267027
RGD:11354977
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il7
interleukin 7
IEP
mRNA:increased expression:liver
RGD
PMID:17532783
RGD:10402939
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
Itga4
integrin subunit alpha 4
treatment
ISO
RGD
PMID:9721793
RGD:9698437
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Kdr
kinase insert domain receptor
ISO
RGD
PMID:22997228
RGD:8549738
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IEP
mRNA:increased expression:liver:
RGD
PMID:9862859
RGD:12910749
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Klrk1
killer cell lectin like receptor K1
IEP
RGD
PMID:20306467
RGD:9685184
NCBI chr 4:163,079,887...163,092,434
Ensembl chr 4:163,081,927...163,092,459
G
Lta
lymphotoxin alpha
treatment
IEP IMP
RGD
PMID:8356596 PMID:2338821
RGD:8548835 , RGD:8548836
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
RGD
PMID:12717211
RGD:7349372
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Muc4
mucin 4, cell surface associated
IEP
RGD
PMID:12717211
RGD:7349372
NCBI chr11:68,008,245...68,053,242
G
Myc
MYC proto-oncogene, bHLH transcription factor
IMP
cornea
RGD
PMID:22149555
RGD:7240566
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nfkbia
NFKB inhibitor alpha
treatment
ISO IEP
RGD
PMID:19399405 PMID:31828147
RGD:10413870 , RGD:35316072
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:29218089
RGD:13504718
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nppa
natriuretic peptide A
treatment
ISO
RGD
PMID:23826817
RGD:7297054
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:decreased activity:blood, mononuclear cell
RGD
PMID:10959477
RGD:7174721
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Pdcd1
programmed cell death 1
severity
ISO
mRNA:increased expression:leukocytes, Mononuclear:
RGD
PMID:21518556 PMID:17198268 PMID:17489865
RGD:7248673 , RGD:9589063 , RGD:9589060
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdgfd
platelet derived growth factor D
IEP
RGD
PMID:19213942
RGD:9854642
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Pdgfrb
platelet derived growth factor receptor beta
IMP
RGD
PMID:10458478
RGD:1625382
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
IMP
RGD
PMID:17311089
RGD:8693431
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
G
Plat
plasminogen activator, tissue type
susceptibility
ISO
protein:increased expression:plasma (human)
RGD
PMID:11423054
RGD:11541079
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
mRNA, protein:increased expression:kidney (human)
RGD
PMID:14531820
RGD:7241140
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Prrc2a
proline-rich coiled-coil 2A
susceptibility
ISO
DNA:haplotype: :rs11538264(human)
RGD
PMID:25111513
RGD:14390152
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Psmb9
proteasome 20S subunit beta 9
severity
IEP
protein:increased expression:liver, kidney (rat)
RGD
PMID:22834313
RGD:9854627
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Raet1l
retinoic acid early transcript 1L
IEP
RGD
PMID:20306467
RGD:9685184
NCBI chr 1:1,979,433...1,984,410
Ensembl chr 1:1,979,443...1,984,410
G
Raet1ll1
retinoic acid early transcript 1L like 1
IEP
RGD
PMID:20306467
RGD:9685184
NCBI chr 1:1,397,219...1,437,802
Ensembl chr 1:1,397,230...1,402,656
G
Rapgef3
Rap guanine nucleotide exchange factor 3
treatment
IDA
RGD
PMID:18178058
RGD:9835362
NCBI chr 7:128,875,772...128,898,203
Ensembl chr 7:128,875,773...128,898,521
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:31828147
RGD:35316072
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
treatment
IMP
RGD
PMID:23196258
RGD:7777161
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
RT1-Bb
RT1 class II, locus Bb
IDA
RGD
PMID:1547813
RGD:7421554
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-CE13
RT1 class I, locus CE13
treatment
ISO
human peptide in rat model; HLA-B7
RGD
PMID:9233694
RGD:7387273
NCBI chr20:3,314,830...3,318,106
G
Sell
selectin L
ISO
RGD
PMID:11095659
RGD:7175511
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc5a7
solute carrier family 5 member 7
IEP
protein:increased expression:kidney, mononuclear cell
RGD
PMID:19201987
RGD:9999387
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
G
Spi1
Spi-1 proto-oncogene
treatment
IMP
RGD
PMID:24282365
RGD:9586451
NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393
G
Stat4
signal transducer and activator of transcription 4
ISO
DNA:SNP: :rs7574865 (human)
RGD
PMID:21237270
RGD:7207871
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tbxa2r
thromboxane A2 receptor
IMP
RGD
PMID:7964472
RGD:11059606
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tlr2
toll-like receptor 2
ISO IEP
liver;DNA:SNP: :p.R753Q (human) kidney
RGD
PMID:22042224 PMID:20038715 PMID:20090572 PMID:20628182 PMID:20628182
RGD:7207901 , RGD:7240555 , RGD:7240554 , RGD:7240551 , RGD:7240551
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
ISO
pancreatic islet
RGD
PMID:20642685 PMID:20038715
RGD:7240548 , RGD:7240555
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
susceptibility
ISO
kidney; DNA:snp:exon:g.+2848G>A rs352140 (human, North Indian)
RGD
PMID:22251233
RGD:7246885
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
IMP ISO IEP
protein:increased expression:heart,serum:
RGD
PMID:2038191 PMID:2338821 PMID:8094579 PMID:2038191
RGD:7394793 , RGD:8548836 , RGD:7401188 , RGD:7394793
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1b
TNF receptor superfamily member 1B
IEP
RGD
PMID:19298452
RGD:7245520
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tpmt
thiopurine S-methyltransferase
ISO
RGD
PMID:24121523
RGD:11038722
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Tpo
thyroid peroxidase
ISO
RGD
PMID:19506389
RGD:7207487
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Traf2
Tnf receptor-associated factor 2
treatment
IEP
RGD
PMID:31828147
RGD:35316072
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Xdh
xanthine dehydrogenase
treatment
IMP
RGD
PMID:24768926
RGD:13209011
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
F3
coagulation factor III, tissue factor
IEP
RGD
PMID:9916935
RGD:11341701
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
ISO
RGD
PMID:21489814
RGD:155260371
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
G
Pdgfd
platelet derived growth factor D
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:22217518 PMID:23769041
RGD:7245568 , RGD:8695995
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
C3
complement C3
treatment
IDA
RGD
PMID:25122638
RGD:11040803
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:22826618
RGD:11352297
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA
liver
RGD
PMID:22826618
RGD:11352297
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
F7
coagulation factor VII
treatment
ISO
human protein in a rat model
RGD
PMID:12095034
RGD:11049508
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:22217518
RGD:7245568
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
IMP
RGD
PMID:24312257
RGD:401700379
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Mtor
mechanistic target of rapamycin kinase
treatment
IDA
RGD
PMID:23985719
RGD:10041002
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Tnf
tumor necrosis factor
treatment
IMP
RGD
PMID:24598936
RGD:10450586
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Aco1
aconitase 1
IEP
RGD
PMID:20176611
RGD:11541086
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
disease_progression
IEP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Clu
clusterin
treatment
IEP
RGD
PMID:22494435
RGD:9068431
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:20005400
RGD:243048470
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
treatment
IDA
RGD
PMID:18209025
RGD:9685339
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Pdgfa
platelet derived growth factor subunit A
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Serpine1
serpin family E member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Epas1
endothelial PAS domain protein 1
IEP
mRNA:increased expression:lung
RGD
PMID:22305384
RGD:10395369
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Cd274
CD274 molecule
treatment
IMP
RGD
PMID:22300371
RGD:41412184
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd4
Cd4 molecule
treatment
IMP
RGD
PMID:1358194
RGD:10059315
NCBI chr 4:157,668,878...157,695,366
G
Il1rn
interleukin 1 receptor antagonist
ISO
human gene in a rat model
RGD
PMID:23723965
RGD:9684950
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP: :rs17817449 (human)
RGD
PMID:30408245
RGD:329845888
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
Ccn2
cellular communication network factor 2
exacerbates
IEP
protein:increased expression:urine (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:12244161
RGD:7248713
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:29290803
RGD:401827126
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Icam1
intercellular adhesion molecule 1
treatment
IMP
RGD
PMID:22617707 PMID:10666412
RGD:8547722 , RGD:11520779
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911153
RGD:11049478
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Npy
neuropeptide Y
IEP
mRNA, protein:decreased expression:blood, mononuclear cell
RGD
PMID:18981110
RGD:10448956
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Pf4
platelet factor 4
ameliorates
IDA
RGD
PMID:24986443
RGD:329901907
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Selp
selectin P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Senp1
SUMO specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
G
Tnf
tumor necrosis factor
treatment
IEP
liver
RGD
PMID:18972563
RGD:15023490
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all